Latvia Business News API

{
    "totalArticles": 32032,
    "articles": [
        {
            "id": "5c551e61cad95fe199dcbfa471220bcd",
            "title": "Arcus Biosciences Announces New Employment Inducement Grants",
            "description": "Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therap...",
            "content": "HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune ... [1600 chars]",
            "url": "https://www.businesswire.com/news/home/20260609426682/en/Arcus-Biosciences-Announces-New-Employment-Inducement-Grants",
            "image": "https://www.businesswire.com/bw-logo.png",
            "publishedAt": "2026-06-09T20:35:00Z",
            "lang": "en",
            "source": {
                "id": "faa207db5381edc12400fbb5c91df94e",
                "name": "Business Wire",
                "url": "https://www.businesswire.com"
            }
        },
        {
            "id": "d29099038f30f7d74cce271dc4ed4e01",
            "title": "U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease",
            "description": "Takeda (TSE:4502/NYSE:TAK) today announced the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application...",
            "content": "OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for intravenous (IV) ENTYVIO® (vedo... [13333 chars]",
            "url": "https://www.businesswire.com/news/home/20260608352333/en/U.S.-FDA-Accepts-Takedas-Application-for-Intravenous-ENTYVIO-vedolizumab-in-Pediatric-Ulcerative-Colitis-and-Crohns-Disease",
            "image": "https://www.businesswire.com/bw-logo.png",
            "publishedAt": "2026-06-09T20:30:00Z",
            "lang": "en",
            "source": {
                "id": "faa207db5381edc12400fbb5c91df94e",
                "name": "Business Wire",
                "url": "https://www.businesswire.com"
            }
        },
        {
            "id": "67678c966d53bc17243dca0b6b18f79e",
            "title": "EnerSys Introduces DataSafe Noir™ Lithium System for Data Center Power",
            "description": "EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial applications, today introduced the DataSafe Noir™ lithium-based energy storage...",
            "content": "READING, Pa.--(BUSINESS WIRE)--EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial applications, today introduced the DataSafe Noir™ lithium-based energy storage system engineered to control how power behaves under real-wor... [3624 chars]",
            "url": "https://www.businesswire.com/news/home/20260609066236/en/EnerSys-Introduces-DataSafe-Noir-Lithium-System-for-Data-Center-Power",
            "image": "https://mms.businesswire.com/media/20260609066236/en/1858212/22/EnerSys_logo_color.jpg",
            "publishedAt": "2026-06-09T20:15:00Z",
            "lang": "en",
            "source": {
                "id": "faa207db5381edc12400fbb5c91df94e",
                "name": "Business Wire",
                "url": "https://www.businesswire.com"
            }
        }
    ]
}